Xinwei Han
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Ferroptosis and cancer prognosis 33
- Tracheal and airway disorders 18
- Oncology 54
- Cancer Immunotherapy and Biomarkers 24
- Co-authors
- Zaoqu Liu (59 shared papers)Libo Wang (40 shared papers)Dechao Jiao (36 shared papers)Kongming Wu (6 shared papers)Chunguang Guo (32 shared papers)Siyuan Weng (58 shared papers)Qin Dang (27 shared papers)Long Liu (38 shared papers)
- Journals
- Frontiers in Oncology (9 papers)Frontiers in Immunology (7 papers)Frontiers in Cell and Developmental Biology (6 papers)Molecular Cancer (6 papers)Acta Radiologica (5 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Xinwei Han
167 papers receiving 4.5k citations
Xinwei Han's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 999
- Oncology 1.8k
- Immunology 972
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 1.7k
Countries citing papers authored by Xinwei Han
This map shows the geographic impact of Xinwei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinwei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinwei Han more than expected).
Fields of papers citing papers by Xinwei Han
This network shows the impact of papers produced by Xinwei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinwei Han. The network helps show where Xinwei Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinwei Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors Hit paper breakdown → | 2018 | 573 |
| 2 | Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer Hit paper breakdown → | 2022 | 455 |
| 3 | Immunosenescence: molecular mechanisms and diseases Hit paper breakdown → | 2023 | 421 |
| 4 | 2017 | 234 | |
| 5 | 2017 | 131 | |
| 6 | 2022 | 115 | |
| 7 | 2022 | 95 | |
| 8 | 2018 | 87 | |
| 9 | Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy Hit paper breakdown → | 2023 | 84 |
| 10 | 2017 | 83 | |
| 11 | 2023 | 79 | |
| 12 | 2021 | 76 | |
| 13 | 2023 | 65 | |
| 14 | 2022 | 62 | |
| 15 | 2022 | 61 | |
| 16 | 2022 | 60 | |
| 17 | 2017 | 60 | |
| 18 | 2016 | 59 | |
| 19 | 2023 | 59 | |
| 20 | 2022 | 57 |
About Xinwei Han
Xinwei Han is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 175 papers that have together received 4.6k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (33 papers), Cancer Immunotherapy and Biomarkers (24 papers), Cancer-related molecular mechanisms research (19 papers), Tracheal and airway disorders (18 papers), RNA modifications and cancer (16 papers), Cancer Genomics and Diagnostics (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (14 papers) and Esophageal and GI Pathology (13 papers). The work is most often cited by research in Cancer Research (999 citations), Oncology (1.8k citations), Immunology (972 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Molecular Biology (1.7k citations). Xinwei Han has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Zaoqu Liu, Libo Wang, Dechao Jiao, Kongming Wu, Chunguang Guo, Siyuan Weng, Qin Dang, Long Liu, Yuqing Ren and Zaoqu Liu. Their work appears in journals such as Frontiers in Oncology, Frontiers in Immunology, Frontiers in Cell and Developmental Biology, Molecular Cancer and Acta Radiologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.